Delivery Order SPE2DR25D7005-SPE2DR26F3FBA
- Not listed
- The Defense Logistics Agency awarded a $1,127.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/ml vials, with a completion date of January 20, 2026. This non-set-aside, competitively awarded contract reflects standard pharmaceutical procurement practices for federal medical supply chain operations. The contract will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,312.85 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL). The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2026, and was competitively awarded with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a task order under AmerisourceBergen's parent company...
- The Defense Logistics Agency's Medical Supply Chain awarded a $4,366.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials. The contract, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle. Performance will be executed at the company's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,109.75 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL syringes (10 mL units). The contract, awarded on January 9, 2026, with an ultimate completion date of January 12, 2026, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will occur at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a $12,393.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/10 mL in quantities of 10 units, with an ultimate completion date of December 29, 2025. This non-set-aside contract was competitively awarded on December 1, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,750.20 delivery order to AmerisourceBergen Drug Corp for Atropine 1 mg/ml vials, with an ultimate completion date of September 8, 2025. This non-set-aside, competitively awarded contract features firm fixed pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,576.02 to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials on January 29, 2026. The contract is competitively awarded with no set-aside designation and carries a firm fixed-price structure with a completion date of January 30, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., serves as a critical...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Atropine 1 mg/mL vials under a firm fixed-price contract valued at $16,471.67. The contract was competitively awarded without set-aside provisions and requires completion by June 9, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1.74K to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Atropine 8 mg/20 mL vials. The contract is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply contract. This delivery order falls...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 10, 2025, for the supply of Atropine 1 mg/mL vials valued at $3,459.76. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3FBADelivery Order
The Defense Logistics Agency awarded a $4,690.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Atropine 1 mg/mL vials. This is a non-set-aside competitive award with an ultimate completion date of January 30, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. This contract reflects AmerisourceBergen's critical role as a pharmaceutical distributor to the Department of Defense medical supply chain. The atropine product supports military medical treatment facilities and defense healthcare operations, consistent with the company's extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains. The underlying indefinite delivery contract encompasses specialty medications, brand-name and generic drugs, vaccines, medical devices, and other medical commodities necessary to sustain military healthcare capabilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 1/28/26 |